International Biotechnology (IBT) Stock Chart & Stock Price History

International Biotechnology logo
GBX 1,060 0.00 (0.00%)
As of 12:03 PM Eastern

International Biotechnology Stock Price Performance

The International Biotechnology (IBT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 79.66%, with a year-to-date return of 9.96%. In the past month, the stock has increased 8.38%, reflecting recent market activity.

As of the latest close, International Biotechnology traded at GBX 1,060 with a market cap of £337.38 million and volume of 59,444 shares. Five years ago, the stock traded at GBX 744, representing a 42.47% increase over that period. At the time, it had a market cap of £305.96 million and a volume of 78,921 shares.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+6.85%
1 Month
Performance
+8.38%
3 Month
Performance
+21.00%
Year-To-Date
Performance
+9.96%
1 Year
Performance
+79.66%
5 Year
Performance
+42.47%

IBT Stock Chart for Friday, June, 26, 2026

International Biotechnology Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
06/25/2026GBX 1,050GBX 1,060
+0.95%
GBX 1,065GBX 1,04059,444 shs£337.38 million
06/24/2026GBX 1,030GBX 1,050
+1.94%
GBX 1,050GBX 1,029.4045,173 shs£334.19 million
06/23/2026GBX 1,015GBX 1,030
+1.48%
GBX 1,030GBX 99843,674 shs£327.83 million
06/22/2026GBX 1,000GBX 1,015
+1.50%
GBX 1,015GBX 98648,801 shs£323.05 million
06/19/2026GBX 992GBX 1,000
+0.81%
GBX 1,000GBX 99092,222 shs£318.28 million
06/18/2026GBX 970GBX 992
+2.27%
GBX 998.22GBX 98462,298 shs£315.73 million
06/17/2026GBX 966GBX 970
+0.41%
GBX 990GBX 96635,549 shs£308.73 million
06/16/2026GBX 974GBX 966
-0.82%
GBX 974GBX 95425,689 shs£307.46 million
06/15/2026GBX 956GBX 974
+1.88%
GBX 974GBX 951.7671,007 shs£310.01 million
06/12/2026GBX 948GBX 956
+0.84%
GBX 960GBX 95062,941 shs£304.28 million
06/11/2026GBX 950GBX 948
-0.21%
GBX 950GBX 93230,942 shs£301.73 million
06/10/2026GBX 942.64GBX 950
+0.78%
GBX 956.56GBX 94055,917 shs£302.37 million
06/09/2026GBX 934GBX 942.64
+0.92%
GBX 955.15GBX 933.1027,548 shs£300.02 million
06/08/2026GBX 954GBX 934
-2.10%
GBX 950GBX 93226,732 shs£297.27 million
06/05/2026GBX 966GBX 954
-1.24%
GBX 968GBX 95231,825 shs£303.64 million
06/04/2026GBX 938GBX 966
+2.99%
GBX 970GBX 93839,518 shs£307.46 million
06/03/2026GBX 962GBX 938
-2.49%
GBX 960GBX 93250,462 shs£298.55 million
06/02/2026GBX 980GBX 962
-1.84%
GBX 984GBX 955.1081,553 shs£306.19 million
06/01/2026GBX 988GBX 980
-0.81%
GBX 1,003.85GBX 96476,367 shs£311.91 million
05/29/2026GBX 986GBX 988
+0.20%
GBX 1,005GBX 98426,954 shs£314.46 million
05/28/2026GBX 992GBX 986
-0.60%
GBX 996GBX 97681,965 shs£313.82 million
05/27/2026GBX 978GBX 992
+1.43%
GBX 992GBX 97432,148 shs£315.73 million
05/26/2026GBX 986GBX 978
-0.81%
GBX 992GBX 97622,260 shs£311.28 million
05/25/2026GBX 986GBX 986GBX 994GBX 982.1620,266 shs£313.82 million

This page (LON:IBT) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners